Advertisement

Duodenal–jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion

Published:December 23, 2014DOI:https://doi.org/10.1016/j.soard.2014.12.017

      Abstract

      Background

      Laparoscopic sleeve gastrectomy (SG) has become accepted as a stand-alone procedure as a less complex operation than laparoscopic duodenojejunal bypass with sleeve gastrectomy (DJB-SG).

      Objectives

      The aim of this study was to compare one-year results between DJB-SG and SG.

      Setting

      University hospital.

      Methods

      A total of 89 patients who received a DJB-SG surgery were matched with a group of SG that were equal in age, sex, and body mass index (BMI). Complication rates, weight loss, and remission of co-morbidities were evaluated after 12 months.

      Results

      The mean preoperative patient BMI in the DJB-SG and SG groups was similar. There were more patients with type 2 diabetes mellitus (T2DM) in the DJB-SG group than in the SG group. The mean operative time and length of hospital stay (LOS) were significantly longer in the DJB-SG group than in the SG group. At 12 months after surgery, the BMI was lower and excess weight loss higher in DJB-SG than SG. Remission of T2DM was greater in the DJB-SG group. Low-density lipoprotein, total cholesterol, and metabolic syndrome (MS) improved after operation in both groups.

      Conclusions

      In this study DJB-SG was superior to SG in T2DM remission, triglyceride improvement, excess weight loss, and lower BMI at 1 year after surgery. Adding duodenal switch to sleeve gastrectomy increases the effect of diabetic control and MS resolution.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery for Obesity and Related Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Flegal K.M.
        • Carroll M.D.
        • Kit B.K.
        • Ogden C.L.
        Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.
        JAMA. 2012; 307: 491-497
        • Zimmet P.
        • Alberti K.G.
        • Shaw J.
        Global and societal implications of the diabetes epidemic.
        Nature. 2001; 414: 782-787
        • Buchwald H.
        • Oien D.M.
        Metabolic/bariatric surgery worldwide 2011.
        Obes Surg. 2013; 23: 427-436
        • Buchwald H.
        • Avidor Y.
        • Braunwald E.
        • et al.
        Bariatric surgery: a systematic review and meta-analysis.
        JAMA. 2004; 292: 1724-1737
        • Kral J.G.
        • Naslund E.
        Surgical treatment of obesity.
        Nat Clin Pract Endocrinol Metab. 2007; 3: 574-583
        • Karamanakos S.N.
        • Vagenas K.
        • Kalfarentzos F.
        • Alexandrides T.K.
        Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study.
        Ann Surg. 2008; 247: 401-407
        • Vidal P.
        • Ramon J.M.
        • Goday A.
        • et al.
        Laparoscopic gastric bypass versus laparoscopic sleeve gastrectomy as a definitive surgical procedure for morbid obesity. Mid-term results.
        Obes Surg. 2013; 23: 292-299
        • Sasaki A.
        • Wakabayashi G.
        • Yonei Y.
        Current status of bariatric surgery in Japan and effectiveness in obesity and diabetes.
        J Gastroenterol. 2014; 49: 57-63
        • Ohta M.
        • Kitano S.
        • Kasama K.
        • et al.
        Results of a national survey on laparoscopic bariatric surgery in Japan, 2000-2009.
        Asian J Endosc Surg. 2011; 4: 138-142
        • Lee W.J.
        • Ser K.H.
        • Chong K.
        • et al.
        Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion.
        Surgery. 2010; 147: 664-669
        • Schauer P.R.
        • Bhatt D.L.
        • Kirwan J.P.
        • et al.
        Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.
        N Engl J Med. 2014; 370: 2002-2013
        • Lee W.J.
        • Chong K.
        • Ser K.H.
        • et al.
        Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial.
        Arch Surg. 2011; 146: 143-148
        • Thaler J.P.
        • Cummings D.E.
        Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery.
        Endocrinology. 2009; 150: 2518-2525
        • Kasama K.
        • Tagaya N.
        • Kanehira E.
        • et al.
        Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results.
        Obes Surg. 2009; 19: 1341-1345
        • Raj P.P.
        • Kumaravel R.
        • Chandramaliteeswaran C.
        • Vaithiswaran V.
        • Palanivelu C.
        Laparoscopic duodenojejunal bypass with sleeve gastrectomy: preliminary results of a prospective series from India.
        Surg Endosc. 2012; 26: 688-692
        • Gagner M.
        Laparoscopic sleeve gastrectomy with duodenojejunal bypass for severe obesity and/or type 2 diabetes may not require duodenojejunal bypass initially.
        Obes Surg. 2010; 20 (author reply 5–6): 1323-1324
        • Lee W.J.
        • Wang W.
        Bariatric surgery: Asia-Pacific perspective.
        Obes Surg. 2005; 15: 751-757
        • Dixon J.B.
        • Zimmet P.
        • Alberti K.G.
        • Rubino F.
        International Diabetes Federation Taskforce on E, Prevention. Bariatric surgery: an IDF statement for obese Type 2 diabetes.
        Diabet Med. 2011; 28: 628-642
        • Lee W.J.
        • Wang W.
        • Lee Y.C.
        • Huang M.T.
        • Ser K.H.
        • Chen J.C.
        Laparoscopic mini-gastric bypass: experience with tailored bypass limb according to body weight.
        Obes Surg. 2008; 18: 294-299
        • Lee W.J.
        • Lee K.T.
        • Kasama K.
        • et al.
        Laparoscopic single-anastomosis duodenal-jejunal bypass with sleeve gastrectomy (SADJB-SG): short-term result and comparison with gastric bypass.
        Obes Surg. 2014; 24: 109-113
        • Ser K.H.
        • Lee W.J.
        • Lee Y.C.
        • Chen J.C.
        • Su Y.H.
        • Chen S.C.
        Experience in laparoscopic sleeve gastrectomy for morbidly obese Taiwanese: staple-line reinforcement is important for preventing leakage.
        Surg Endosc. 2010; 24: 2253-2259
        • Clavien P.A.
        • Barkun J.
        • de Oliveira M.L.
        • et al.
        The Clavien-Dindo classification of surgical complications: five-year experience.
        Ann Surg. 2009; 250: 187-196
        • Hickey M.S.
        • Pories W.J.
        • MacDonald Jr., K.G.
        • et al.
        A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut?.
        Ann Surg. 1998; 227 (discussion 43–4): 637-643
        • Rubino F.
        • Marescaux J.
        Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.
        Ann Surg. 2004; 239: 1-11
        • Rubino F.
        • Forgione A.
        • Cummings D.E.
        • et al.
        The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.
        Ann Surg. 2006; 244: 741-749
        • Ferzli G.S.
        • Dominique E.
        • Ciaglia M.
        • Bluth M.H.
        • Gonzalez A.
        • Fingerhut A.
        Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis.
        World J Surg. 2009; 33: 972-979
        • De Paula A.L.
        • Stival A.R.
        • Macedo A.
        • et al.
        Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21-34 kg/m(2).
        Surg Obes Relat Dis. 2010; 6: 296-304
        • Paik K.Y.
        • Kim W.
        • Song K.H.
        • Kwon H.S.
        • Kim M.K.
        • Kim E.
        The preliminary clinical experience with laparoscopic duodenojejunal bypass for treatment of type 2 diabetes mellitus in non-morbidly obese patients: the 1-year result in a single institute.
        Surg Endosc. 2012; 26: 3287-3292
        • Jullig M.
        • Yip S.
        • Xu A.
        • et al.
        Lower fetuin-A, retinol binding protein 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes.
        PLoS One. 2014; 9: e96489
        • Escalona A.
        • Guzman S.
        • Ibanez L.
        • Meneses L.
        • Huete A.
        • Solar A.
        Gastric cancer after Roux-en-Y gastric bypass.
        Obes Surg. 2005; 15: 423-427
        • Wu C.C.
        • Lee W.J.
        • Ser K.H.
        • et al.
        Gastric cancer after mini-gastric bypass surgery: a case report and literature review.
        Asian J Endosc Surg. 2013; 6: 303-306